Now loading.
Please wait.

Menu

Dr. Ashok Munivenkatappa

HomeDr. Ashok Munivenkatappa
HomeDr. Ashok Munivenkatappa
single image

Dr. Ashok Munivenkatappa

Designation: Scientist D

Division: Bangalore Unit

Educational qualifications: MBBS, Clinical PhD

Date of joining ICMR-NIV: :22th December 2016

  • Contact: +91-080-26654084
  • Email: munivenkatappa.a@gov.in
  • Office: Indian Council of Medical Research-National Institute of Virology Pune Maharashtra - 411001

 

Research Interests:

  • Virology
  • Neuroscience

 

Awards/Honours:

  • Oral and Poster prizes
  • Three national and one international travels grants travels grants
  • Three internal travel grant from ICMR, CSIR and NSI

 

ORCID ID:0000-0001-8992-8750

Researcher ID:ABA-5952-2021

Google Scholar Profile Link

 

List of Publications
  • 1. Munivenkatappa A, Sahay RR, Gururaj R D, Deepak Y P, Shete AM, Gajanan N, et al.  A case with SARS-CoV-2 reinfection from India. Indian Journal of Medical Microbiology August 2021 (accepted).

  • 2.Rajagopal PM, Prameela D, Rajesh S, Siva A, Shilpa S, Parimala S M, et al. Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India. medRxiv 2021.08.10.21261842;

  • 3. Munivenkatappa A, Nyayanit DA, Yadav PD, Rangappa M, Patil S, Majumdar T, et al.  Identification of Phasi Charoen-Like Phasivirus in Field Collected Aedes aegypti from Karnataka State, India. Vector Borne Zoonotic Dis. 2021 Sep 14.

  • 4. Gupta N, Kaur H, Yadav PD, Mukhopadhyay L, Sahay RR, Kumar A, et al. Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India. Viruses. 2021 Sep 7;13(9):1782. 

  • 5. Babu GR, Sundaresan R, Athreya S, Akhtar J, Pandey PK, Maroor PS, et al. The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India. Int J Infect Dis. 2021 Jul;108:27-36.

  • 6. Yadav PD, Nyayanit DA, Majumdar T, Patil S, Kaur H, Gupta N, et al. An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India. Viruses. 2021 May 17;13(5):925.

  • 7.  Mourya DT, Munivenkatappa A, Reshma K, Yadav P, Gupta N, Manju Rahi. Re-Assessing The Biosafety Level Requirement And Defining Surveillance Need For Kyasanur Forest Disease Virus: Changed Paradigm. Indian J Med Res. (provisionally accepted)

  • 8. Munivenkatappa A, Nyayanit DA, Sreelekshmy M, Asia L, Shete-Aich A, Hanumaiah H, et al. Molecular characterization and recombination analysis of complete Enterovirus-88 isolated from acute flaccid paralysis cases in India. Indian J Med Res. (provisionally accepted)

  • 9. Munivenkatappa A, Yadav PD, Swetha K, Jayaswamy M, Nyayanit DA, Sahay RR, et al. SARS-CoV-2 & influenza A virus co-infection in an elderly patient with pneumonia. Indian J Med Res. 2021 Jan & Feb;153(1 & 2):190-195.

  • 10. Vaidya SR, Kasibhatla SM, Kamble MB, Munivenkatappa A, Kumbhar NS, Jayaswamy MM, et al. Genetic and antigenic characterization of wild type rubella viruses isolated from India. Vaccine. 2021 Feb 5;39(6):876-881.

  • 11. Praharaj I, Jain A, Singh M, Balakrishnan A, Dhodapkar R, Borkakoty B, et al. Pooled testing for COVID-19 diagnosis by real-time RT-PCR: A multi-site comparative evaluation of 5- & 10-sample pooling. Indian J Med Res. 2020 Jul & Aug;152(1 & 2):88-94.

  • 12.  Gupta N, Potdar V, Praharaj I, Giri S, Sapkal G, Yadav P, et al. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020 Feb & Mar;151(2 & 3):216-225.

  • 13. Sapkal G, Shete-Aich A, Jain R, Yadav PD, Sarkale P, Lakra R, et al. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG. Indian J Med Res. 2020 May;151(5):444-449. 

  • 14. Murhekar M, Verma S, Singh K, Bavdekar A, Benakappa N, Santhanam S, et al. Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance. PLoS Negl Trop Dis. 2020 Feb 3;14(2):e0007982. 

  • 15. Alagarasu K, Patil JA, Kakade MB, More AM, Bote M, Chowdhury D, et al. Spatio-temporal distribution analysis of circulating genotypes of dengue virus type 1 in western and southern states of India by a one-step real-time RT-PCR assay. Infect Genet Evol. 2019 Nov;75:103989. 

  • 16. Munivenkatappa A, Yadav PD, Nyayanit DA, Majumdar TD, Sangal L, Jain S, et al. Molecular diversity of Coxsackievirus A10 circulating in the southern and northern region of India [2009-17]. Infect Genet Evol. 2018 Dec;66:101-110. 

  • 17. Murhekar MV, Ashok M, Kanagasabai K, Joshua V, Ravi M, Sabarinathan R, et al. Epidemiology of Hepatitis A and Hepatitis E Based on Laboratory Surveillance Data-India, 2014-2017. Am J Trop Med Hyg. 2018 Oct;99(4):1058-1061.

  • 18. Viswanathan R, George S, Murhekar MV, Abraham AM, Singh MP, Jadhav SM, et al. Comparison of two commercial ELISA kits for detection of rubella specific IgM in suspected congenital rubella syndrome cases and rubella IgG antibodies in a serosurvey of pregnant women. Diagn Microbiol Infect Dis. 2019 Jul;94(3):243-247. 

  • 19. Munivenkatappa A, Sahay RR, Yadav PD, Viswanathan R, Mourya DT. Clinical & epidemiological significance of Kyasanur forest disease. Indian J Med Res. 2018 Aug;148(2):145-150.

  • 20. Joshua V, Murhekar MV, Ashok M, Kanagasabai K, Ravi M, Sabarinathan R, et al. Mapping dengue cases through a national network of laboratories, 2014-2015. Indian J Med Res. 2016 Dec;144(6):938-941. 

 

All for Joomla All for Webmasters